To check the efficacy of Pushkarmoola Ghan Vati and Sarpagandha Ghan Vati with Lifestyle Modification in the treatment of stage 1 hypertension

Evaluation of Comparative efficacy of Pushkarmoola Ghan Vati versus Sarpagandha Ghan Vati along with Lifestyle Modifications in the Management of Stage-1 Hypertension - A Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/095504

Enrollment

Registered

2025-09-30

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate with written informed consent. Age between 35-55 years of either sex Subjects having Systolic blood pressure 130- 139 mmHg & Diastolic blood pressure between 80- 89 mmHg (Stage-1 hypertension as per ACC/AHA 2017 guidelines)

Exclusion criteria

Exclusion criteria: Cases of major illness like cardiovascular disorders like cardiogenic shock, unstable angina, aortic stenosis, diabetes mellitus, and renal disorders. Patients taking medication like glucocorticoids Pregnant and lactating women. Patient on antihypertensive and diuretic drugs

Design outcomes

Primary

Measure	Time frame
Reduction in systolic blood pressure (SBP) Reduction in diastolic blood pressure (DBP) Reduction in mean arterial pressure (MAP) Timepoint: 8 weeks	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Rohit Waskar

Mahatma Gandhi Ayurved College Hospital and Research Center

rohit9642@gmail.com7218182090

Outcome results